KBC Group NV Has $5.39 Million Position in Axon Enterprise, Inc. (NASDAQ:AXON)

KBC Group NV decreased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 26.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,069 shares of the biotechnology company’s stock after selling 3,328 shares during the period. KBC Group NV’s holdings in Axon Enterprise were worth $5,390,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. Quent Capital LLC increased its stake in shares of Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after purchasing an additional 75 shares during the last quarter. Prestige Wealth Management Group LLC boosted its stake in Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 44 shares in the last quarter. Brooklyn Investment Group bought a new position in Axon Enterprise in the third quarter valued at about $41,000. Planning Capital Management Corp raised its stake in Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after acquiring an additional 55 shares in the last quarter. Finally, Friedenthal Financial bought a new position in shares of Axon Enterprise in the third quarter worth about $51,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

AXON has been the subject of a number of research analyst reports. JMP Securities upped their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Robert W. Baird raised their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Needham & Company LLC upped their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Finally, TD Cowen started coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $524.85.

Axon Enterprise Trading Up 2.1 %

NASDAQ:AXON opened at $653.43 on Friday. Axon Enterprise, Inc. has a 52 week low of $247.04 and a 52 week high of $698.67. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm’s fifty day moving average is $619.32 and its 200-day moving average is $479.00. The firm has a market cap of $49.82 billion, a P/E ratio of 168.85, a P/E/G ratio of 6.09 and a beta of 1.04.

Insider Activity at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 21,834 shares of Axon Enterprise stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the sale, the insider now owns 154,394 shares in the company, valued at $91,691,508.72. The trade was a 12.39 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the transaction, the director now directly owns 2,392 shares in the company, valued at approximately $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock worth $30,721,337 over the last quarter. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.